“A Reduced Fixed Dose of Tocilizumab 200 Mg Compared to 400 Mg in Patients With Severe COVID-19 Disease”. 2023. One Health & Risk Management 4 (4): 19-26. https://doi.org/10.38045/ohrm.2023.4.02.